US biotechnology company invests at Klaipėda FEZ FlexStart facility
American capital biotechnology company Cureline Inc. is investing EUR 3.5 million in the construction of a new biotechnology plant and research laboratory in Klaipėda FEZ. The plant, laboratory and administrative premises will be located in the FlexStart facility. The start of operations is planned for the first half of 2024. The new plant and laboratory […]